Keywords: inhibitex, raises, 41m, private, financing, biopharmaceuticals, firm
Inhibitex raises $41M in private financing
Article | 22 August 2005
US biopharmaceuticals firm Inhibitex says that it has entered into definitive purchase agreements to raise approximately $41.0 million through a private ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
